ADC Manufacturing involves the complex production of Antibody-Drug Conjugates, which are targeted cancer therapies that combine the specificity of antibodies with the potency of cytotoxic drugs. This process requires precise chemical conjugation techniques to attach the cytotoxic payload to the antibody via stable linkers. ADC Manufacturing must adhere to stringent quality control and Good Manufacturing Practice (GMP) standards to ensure the stability, efficacy, and safety of the final product.